TP53 and neoplasm: Importantly, examination of whether inhibition of FGF signaling by AZD4547 (or other FGFR inhibitors) in MB tumor-bearing Sufu;Trp53-dKO mice is crucial to establish that FGF signaling is a druggable target for SUFU-associated infantile MBSHH.